Profile of Trofinetide in the Treatment of Rett Syndrome: Design, Development and Potential Place in Therapy
Drug Design, Development and Therapy · 2024-11 · Volume 18 · 5023-5040
DOI: 10.2147/dddt.s383133 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2024-11. Verfasst von Laura Camillo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, LC, Italy. Hauptthemen laut MEDLINE: Rett Syndrome. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, LC, Italy.
- Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, NA, Italy.
- Department of Translational Medical Sciences, University Federico II, Naples, NA, Italy.
ORCID-Profile: Marco Pozzi, Simone Pisano
Zitieren
APA
Camillo, L., Pozzi, M., Bernardo, P., Pisano, S., & Nobile, M. (2024). Profile of Trofinetide in the Treatment of Rett Syndrome: Design, Development and Potential Place in Therapy. Drug Design, Development and Therapy, Volume 18, 5023-5040. https://doi.org/10.2147/dddt.s383133
Vancouver
Camillo L, Pozzi M, Bernardo P, Pisano S, Nobile M. Profile of Trofinetide in the Treatment of Rett Syndrome: Design, Development and Potential Place in Therapy. Drug Design, Development and Therapy. 2024;Volume 18:5023-5040. doi:10.2147/dddt.s383133
BibTeX
@article{Camillo2024,
author = {Camillo, Laura and Pozzi, Marco and Bernardo, Pia and Pisano, Simone and Nobile, Maria},
title = {Profile of Trofinetide in the Treatment of Rett Syndrome: Design, Development and Potential Place in Therapy},
journal = {Drug Design, Development and Therapy},
year = {2024},
volume = {Volume 18},
pages = {5023--5040},
doi = {10.2147/dddt.s383133}
}
EUVIMED